Tag - Aurinia

Executive Moves

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Peter Greenleaf as CEO, and George Milne Jr. as chairman of the board.

April 12, 2019

Feature

Aurinia readies Phase 2b trial in lupus nephritis

By Len Zehr Aurinia Pharmaceuticals (TSX-V:AUP) is preparing to begin a Phase 2b clinical trial in the first quarter of 2014 with its voclosporin immunosuppressant in combination with CellCept, the standard of care for...

November 19, 2013

Tag - Aurinia

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Aurinia readies Phase 2b trial in lupus nephritis

General

More